Research ArticleOriginal Article
Open Access

Analysis of key lncRNA related to Parkinson’s disease based on gene co-expression weight networks

Wenwen Liang, Wei Zhao, Binghan Li, Jiaying Luo, Xuemei Li and Weihua Jia
Neurosciences Journal January 2025, 30 (1) 20-29; DOI: https://doi.org/10.17712/nsj.2025.1.20230112

References

  1. 1.↵
    1. Erkkinen MG,
    2. Kim MO,
    3. Geschwind MD.
    Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases. Cold Spring Harb Perspect Biol 2018; 10: a033118.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. McGregor MM,
    2. Nelson AB.
    Circuit Mechanisms of Parkinson’s Disease. Neuron 2019; 101: 1042-1056.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Tysnes OB,
    2. Storstein A.
    Epidemiology of Parkinson’s disease. J Neural Transm (Vienna) 2017; 124: 901-905.
    OpenUrlPubMed
  4. 4.↵
    1. Cabreira V,
    2. Massano J.
    [Parkinson’s Disease: Clinical Review and Update]. Acta Med Port 2019; 32: 661-670. Portuguese
    OpenUrlPubMed
  5. 5.↵
    1. Jankovic J,
    2. Tan EK.
    Parkinson’s disease: etiopathogenesis and treatment. J Neurol Neurosurg Psychiatry 2020; 91: 795-808.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Alonso Canovas A,
    2. Luquin Piudo R,
    3. Garcia Ruiz-Espiga P,
    4. Burguera JA,
    5. Arillo CV,
    6. Castro A, et al.
    Dopaminergic agonists in Parkinson’s disease. Neurologia 2014; 29: 230-241.
    OpenUrlPubMed
  7. 7.↵
    1. Zhang X,
    2. Wang W,
    3. Zhu W,
    4. Dong J,
    5. Cheng Y,
    6. Yin Z, et al.
    Mechanisms and Functions of Long Non-Coding RNAs at Multiple Regulatory Levels. Int J Mol Sci 2019; 20: 5573.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Dykes IM,
    2. Emanueli C.
    Transcriptional and Post-transcriptional Gene Regulation by Long Non-coding RNA. Genomics Proteomics Bioinformatics 2017; 15: 177-186.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Clark BS,
    2. Blackshaw S.
    Understanding the Role of lncRNAs in Nervous System Development. Adv Exp Med Biol 2017; 1008: 253-282.
    OpenUrlPubMed
  10. 10.↵
    1. Zhang Li-Min,
    2. Meng-Han Wang,
    3. Yang He-Cheng,
    4. Tian T,
    5. Sun Gui-Fang,
    6. Ji Yang-Fei, et al.
    Dopaminergic neuron injury in Parkinson’s disease is mitigated by interfering lncRNA SNHG14 expression to regulate the miR-133b/alpha-synuclein pathway. Aging (Albany NY) 2019; 11: 9264-9279.
    OpenUrlPubMed
  11. 11.↵
    1. Peng T,
    2. Liu X,
    3. Wang J,
    4. Liu Y,
    5. Fu Z,
    6. Ma X, et al.
    Long noncoding RNA HAGLROS regulates apoptosis and autophagy in Parkinson’s disease via regulating miR-100/ATG10 axis and PI3K/Akt/mTOR pathway activation. Artif Cells Nanomed Biotechnol 2019; 47: 2764-2774.
    OpenUrlPubMed
  12. 12.↵
    1. Kraus TFJ,
    2. Haider M,
    3. Spanner J,
    4. Steinmaurer M,
    5. Dietinger V,
    6. Kretzschmar HA, et al.
    Altered Long Noncoding RNA Expression Precedes the Course of Parkinson’s Disease-a Preliminary Report. Mol Neurobiol 2017; 54: 2869-2877.
    OpenUrlPubMed
  13. 13.↵
    1. Lv Q,
    2. Wang Z,
    3. Zhong Z,
    4. Huang W.
    Role of Long Noncoding RNAs in Parkinson’s Disease: Putative Biomarkers and Therapeutic Targets. Parkinsons Dis 2020; 2020: 5374307.
    OpenUrlPubMed
  14. 14.↵
    1. Boon RA,
    2. Jae N,
    3. Holdt L,
    4. Dimmeler S.
    Long Noncoding RNAs: From Clinical Genetics to Therapeutic Targets? J Am Coll Cardiol 2016; 67: 1214-1226.
    OpenUrlFREE Full Text
  15. 15.↵
    1. Yang M,
    2. Wu Xing-Quan,
    3. Ding Chuan-Bo,
    4. Zhang Guo-Feng,
    5. Li M,
    6. Lv Li-Na, et al.
    Weighted gene co-expression network analysis identifies specific modules and hub genes related to Parkinson’s disease. Neuroreport 2021; 32: 1073-1081.
    OpenUrlPubMed
  16. 16.↵
    1. Hu X,
    2. Shen G,
    3. Lu X,
    4. Ding G,
    5. Shen L.
    Identification of key proteins and lncRNAs in hypertrophic cardiomyopathy by integrated network analysis. Arch Med Sci 2019; 15: 484-497.
    OpenUrlPubMed
  17. 17.↵
    1. Chen S,
    2. Ma Q,
    3. Xue Y,
    4. Zhang J,
    5. Yang G,
    6. Wang T, et al.
    Comprehensive Analysis and Co-Expression Network of mRNAs and lncRNAs in Pressure Overload-Induced Heart Failure. Front Genet 2019; 10: 1271.
    OpenUrlPubMed
  18. 18.↵
    1. Harbron C,
    2. Chang KM,
    3. South MC.
    RefPlus: an R package extending the RMA Algorithm. Bioinformatics 2007; 23: 2493-2494.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Kinsella RJ,
    2. Kähäri A,
    3. Haider S,
    4. Zamora J,
    5. Proctor G,
    6. Giulietta Spudich G, et al.
    Ensembl BioMarts: a hub for data retrieval across taxonomic space. Database (Oxford) 2011; 2011: bar030.
  20. 20.↵
    1. Ritchie ME,
    2. Phipson B,
    3. Wu D,
    4. Hu Y,
    5. Law CW,
    6. Shi W, et al.
    limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 2015; 43: e47.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Langfelder P,
    2. Horvath S.
    WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 2008; 9: 559.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Horvath S,
    2. Dong J.
    Geometric interpretation of gene coexpression network analysis. PLoS Comput Biol 2008; 4: e1000117.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Mason MJ,
    2. Fan G,
    3. Plath K,
    4. Zhou Q,
    5. Horvath S.
    Signed weighted gene co-expression network analysis of transcriptional regulation in murine embryonic stem cells. BMC Genomics 2009; 10: 327.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Yip AM,
    2. Horvath S.
    Gene network interconnectedness and the generalized topological overlap measure. BMC Bioinformatics 2007; 8: 22.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Botia JA,
    2. Vandrovcova J,
    3. Forabosco P, et al.
    An additional k-means clustering step improves the biological features of WGCNA gene co-expression networks. BMC Syst Biol 2017; 11: 47.
    OpenUrlPubMed
  26. 26.↵
    1. Szklarczyk D,
    2. Morris JH,
    3. Cook H,
    4. Kuhn M,
    5. Wyder S,
    6. Simonovic M, et al.
    The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res 2017; 45: D362-D368.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Khan AU,
    2. Akram M,
    3. Daniyal M,
    4. Zainab R.
    Awareness and current knowledge of Parkinson’s disease: a neurodegenerative disorder. Int J Neurosci 2019; 129: 55-93.
    OpenUrlPubMed
  28. 28.↵
    1. Trist BG,
    2. Hare DJ,
    3. Double KL.
    Oxidative stress in the aging substantia nigra and the etiology of Parkinson’s disease. Aging Cell 2019; 18: e13031.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Wang X,
    2. Saegusa H,
    3. Huntula S,
    4. Tanabe T.
    Blockade of microglial Cav1.2 Ca(2+) channel exacerbates the symptoms in a Parkinson’s disease model. Sci Rep 2019; 9: 9138.
    OpenUrlPubMed
  30. 30.↵
    1. Cieri D,
    2. Brini M,
    3. Cali T.
    Emerging (and converging) pathways in Parkinson’s disease: keeping mitochondrial wellness. Biochem Biophys Res Commun 2017; 483: 1020-1030.
    OpenUrlPubMed
  31. 31.↵
    1. Alexoudi A,
    2. Alexoudi I,
    3. Gatzonis S.
    Parkinson’s disease pathogenesis, evolution and alternative pathways: A review. Rev Neurol (Paris) 2018; 174: 699-704.
    OpenUrlPubMed
  32. 32.↵
    1. Kraus TFJ,
    2. Haider M,
    3. Spanner J,
    4. Steinmaurer M,
    5. Dietinger V,
    6. Kretzschmar HA.
    Altered Long Noncoding RNA Expression Precedes the Course of Parkinson’s Disease-a Preliminary Report. Mol Neurobiol 2017; 54: 2869-2877.
    OpenUrlPubMed
  33. 33.↵
    1. Xie N,
    2. Qi J,
    3. Li S,
    4. Deng J,
    5. Chen Y,
    6. Lian Y.
    Upregulated lncRNA small nucleolar RNA host gene 1 promotes 1-methyl-4-phenylpyridinium ion-induced cytotoxicity and reactive oxygen species production through miR-15b-5p/GSK3beta axis in human dopaminergic SH-SY5Y cells. J Cell Biochem 2019; 120: 5790-5801.
    OpenUrlPubMed
  34. 34.↵
    1. Li K,
    2. Wang Z.
    lncRNA NEAT1: Key player in neurodegenerative diseases. Ageing Res Rev 2023; 86: 101878.
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. Huang H,
    2. Zheng S,
    3. Lu M.
    Downregulation of lncRNA MEG3 is involved in Parkinson’s disease. Metab Brain Dis 2021; 36: 2323-2328.
    OpenUrlPubMed
  36. 36.↵
    1. Vijayanathan Y,
    2. Lim FT,
    3. Lim SM,
    4. Long CM,
    5. Tan MP,
    6. Abdul Majeed AB, et al.
    6-OHDA-Lesioned Adult Zebrafish as a Useful Parkinson’s Disease Model for Dopaminergic Neuroregeneration. Neurotox Res 2017; 32: 496-508.
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. Mathews ES,
    2. Appel B.
    Cholesterol Biosynthesis Supports Myelin Gene Expression and Axon Ensheathment through Modulation of P13K/Akt/mTor Signaling. J Neurosci 2016; 36: 7628-7639.
    OpenUrlAbstract/FREE Full Text
  38. 38.↵
    1. Zhang X,
    2. Tang N,
    3. Hadden TJ,
    4. Rishi AK. Akt
    , FoxO and regulation of apoptosis. Biochim Biophys Acta 2011; 1813: 1978-1986.
    OpenUrlCrossRefPubMedWeb of Science
  39. 39.↵
    1. van Wamelen DJ,
    2. Grigoriou S,
    3. Chaudhuri KR, et al.
    Continuous Drug Delivery Aiming Continuous Dopaminergic Stimulation in Parkinson’s Disease. J Parkinsons Dis 2018; 8: S65-S72.
    OpenUrl
  40. 40.↵
    1. Abdullah A,
    2. Mohd Murshid N,
    3. Makpol S.
    Antioxidant Modulation of mTOR and Sirtuin Pathways in Age-Related Neurodegenerative Diseases. Mol Neurobiol 2020; 57: 5193-5207.
    OpenUrlPubMed
  41. 41.↵
    1. Fiscus RR.
    Involvement of cyclic GMP and protein kinase G in the regulation of apoptosis and survival in neural cells [J]. Neurosignals 2002; 11: 175-190.
    OpenUrlCrossRefPubMedWeb of Science
  42. 41.↵
    1. Winkle M,
    2. El-Daly SM,
    3. Fabbri M,
    4. Calin GA.
    Noncoding RNA therapeutics - challenges and potential solutions. Nat Rev Drug Discov. 2021; 20: 629-651.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section